Back to BlackRock, Inc. BlackRock, Inc.

CRVSCRVS
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in CORVUS PHARMACEUTICALS INC

BlackRock, Inc. holds 7.1M shares of CRVS (CORVUS PHARMACEUTICALS INC), worth $106.7M as of 2026-Q2. The position was increased (+15.9% shares). CRVS represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$106.7M

Current Shares

7.1M

Total Value Change

+$100.9M

Total Shares Change

+6.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7.1M
+15.9%
$106.7M0.0%$14.94
35
2026-Q1
Increased
6.2M
+21.8%
$90.1M0.0%$17.53
36
2025-Q4
Increased
5.1M
+7.3%
$38.9M0.0%$7.49
31
2025-Q3
Increased
4.7M
+11.1%
$34.7M0.0%$7.28
32
2025-Q2
Increased
4.2M
+301.0%
$17M0.0%$3.89
46
2025-Q1
Decreased
1.1M
-1.5%
$3.4M0.0%$3.38
0
2024-Q4
New
1.1M
-
$5.7M0.0%$5.25
37

Other major holders of CRVS: STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC, Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used